Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials

BACKGROUND: Left ventricular hypertrophy is a common finding in patients with ischemic heart disease and is associated with mortality in patients with cardiovascular disease (CVD). Metformin, an antidiabetic drug, has been shown to reduce oxidative stress and left ventricular mass index (LVMI) in an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamel, Ahmed M., Sabry, Nirmeen, Farid, Samar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464374/
https://www.ncbi.nlm.nih.gov/pubmed/36088302
http://dx.doi.org/10.1186/s12872-022-02845-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464374/
https://www.ncbi.nlm.nih.gov/pubmed/36088302
http://dx.doi.org/10.1186/s12872-022-02845-w

Ejemplares similares